122 related articles for article (PubMed ID: 38570770)
21. Circulating myeloid cells invade the central nervous system to mediate cachexia during pancreatic cancer.
Burfeind KG; Zhu X; Norgard MA; Levasseur PR; Huisman C; Buenafe AC; Olson B; Michaelis KA; Torres ER; Jeng S; McWeeney S; Raber J; Marks DL
Elife; 2020 May; 9():. PubMed ID: 32391790
[TBL] [Abstract][Full Text] [Related]
22. Hepatic signal transducer and activator of transcription-3 signalling drives early-stage pancreatic cancer cachexia via suppressed ketogenesis.
Arneson-Wissink PC; Mendez H; Pelz K; Dickie J; Bartlett AQ; Worley BL; Krasnow SM; Eil R; Grossberg AJ
J Cachexia Sarcopenia Muscle; 2024 Apr; ():. PubMed ID: 38632714
[TBL] [Abstract][Full Text] [Related]
23. Multi-omic profiling of lung and liver tumor microenvironments of metastatic pancreatic cancer reveals site-specific immune regulatory pathways.
Ho WJ; Erbe R; Danilova L; Phyo Z; Bigelow E; Stein-O'Brien G; Thomas DL; Charmsaz S; Gross N; Woolman S; Cruz K; Munday RM; Zaidi N; Armstrong TD; Sztein MB; Yarchoan M; Thompson ED; Jaffee EM; Fertig EJ
Genome Biol; 2021 May; 22(1):154. PubMed ID: 33985562
[TBL] [Abstract][Full Text] [Related]
24. Small Nucleolar Noncoding RNA SNORA23, Up-Regulated in Human Pancreatic Ductal Adenocarcinoma, Regulates Expression of Spectrin Repeat-Containing Nuclear Envelope 2 to Promote Growth and Metastasis of Xenograft Tumors in Mice.
Cui L; Nakano K; Obchoei S; Setoguchi K; Matsumoto M; Yamamoto T; Obika S; Shimada K; Hiraoka N
Gastroenterology; 2017 Jul; 153(1):292-306.e2. PubMed ID: 28390868
[TBL] [Abstract][Full Text] [Related]
25. Aspartate β-hydroxylase promotes pancreatic ductal adenocarcinoma metastasis through activation of SRC signaling pathway.
Ogawa K; Lin Q; Li L; Bai X; Chen X; Chen H; Kong R; Wang Y; Zhu H; He F; Xu Q; Liu L; Li M; Zhang S; Nagaoka K; Carlson R; Safran H; Charpentier K; Sun B; Wands J; Dong X
J Hematol Oncol; 2019 Dec; 12(1):144. PubMed ID: 31888763
[TBL] [Abstract][Full Text] [Related]
26. Identifying a baicalein-related prognostic signature contributes to prognosis prediction and tumor microenvironment of pancreatic cancer.
Zhang C; Lei D; Zhou Y; Zhong T; Li X; Ai W; Zheng B; Liu J; Piao Y; Yan Z; Lai Z
Front Immunol; 2023; 14():1223650. PubMed ID: 37575248
[TBL] [Abstract][Full Text] [Related]
27. PTEN-Dependent Stabilization of MTSS1 Inhibits Metastatic Phenotype in Pancreatic Ductal Adenocarcinoma.
Zeleniak AE; Huang W; Fishel ML; Hill R
Neoplasia; 2018 Jan; 20(1):12-24. PubMed ID: 29175021
[TBL] [Abstract][Full Text] [Related]
28. Cancer-associated fibroblast heterogeneity is associated with organ-specific metastasis in pancreatic ductal adenocarcinoma.
Pan X; Zhou J; Xiao Q; Fujiwara K; Zhang M; Mo G; Gong W; Zheng L
J Hematol Oncol; 2021 Nov; 14(1):184. PubMed ID: 34727952
[TBL] [Abstract][Full Text] [Related]
29. Metastatic phenotype and immunosuppressive tumour microenvironment in pancreatic ductal adenocarcinoma: Key role of the urokinase plasminogen activator (PLAU).
Hosen SMZ; Uddin MN; Xu Z; Buckley BJ; Perera C; Pang TCY; Mekapogu AR; Moni MA; Notta F; Gallinger S; Pirola R; Wilson J; Ranson M; Goldstein D; Apte M
Front Immunol; 2022; 13():1060957. PubMed ID: 36591282
[TBL] [Abstract][Full Text] [Related]
30. The ARF tumor suppressor inhibits tumor cell colonization independent of p53 in a novel mouse model of pancreatic ductal adenocarcinoma metastasis.
Muniz VP; Barnes JM; Paliwal S; Zhang X; Tang X; Chen S; Zamba KD; Cullen JJ; Meyerholz DK; Meyers S; Davis JN; Grossman SR; Henry MD; Quelle DE
Mol Cancer Res; 2011 Jul; 9(7):867-77. PubMed ID: 21636682
[TBL] [Abstract][Full Text] [Related]
31. Cell of origin affects tumour development and phenotype in pancreatic ductal adenocarcinoma.
Lee AYL; Dubois CL; Sarai K; Zarei S; Schaeffer DF; Sander M; Kopp JL
Gut; 2019 Mar; 68(3):487-498. PubMed ID: 29363536
[TBL] [Abstract][Full Text] [Related]
32. The TLR7/8 agonist R848 remodels tumor and host responses to promote survival in pancreatic cancer.
Michaelis KA; Norgard MA; Zhu X; Levasseur PR; Sivagnanam S; Liudahl SM; Burfeind KG; Olson B; Pelz KR; Angeles Ramos DM; Maurer HC; Olive KP; Coussens LM; Morgan TK; Marks DL
Nat Commun; 2019 Oct; 10(1):4682. PubMed ID: 31615993
[TBL] [Abstract][Full Text] [Related]
33. Loss of the transcriptional repressor TGIF1 results in enhanced Kras-driven development of pancreatic cancer.
Weng CC; Hsieh MJ; Wu CC; Lin YC; Shan YS; Hung WC; Chen LT; Cheng KH
Mol Cancer; 2019 May; 18(1):96. PubMed ID: 31109321
[TBL] [Abstract][Full Text] [Related]
34. Loss of MTSS1 results in increased metastatic potential in pancreatic cancer.
Zeleniak AE; Huang W; Brinkman MK; Fishel ML; Hill R
Oncotarget; 2017 Mar; 8(10):16473-16487. PubMed ID: 28146435
[TBL] [Abstract][Full Text] [Related]
35. Syk Inhibition Reprograms Tumor-Associated Macrophages and Overcomes Gemcitabine-Induced Immunosuppression in Pancreatic Ductal Adenocarcinoma.
Rohila D; Park IH; Pham TV; Weitz J; Hurtado de Mendoza T; Madheswaran S; Ishfaq M; Beaman C; Tapia E; Sun S; Patel J; Tamayo P; Lowy AM; Joshi S
Cancer Res; 2023 Aug; 83(16):2675-2689. PubMed ID: 37306759
[TBL] [Abstract][Full Text] [Related]
36. Involvement of CD40 targeting miR-224 and miR-486 on the progression of pancreatic ductal adenocarcinomas.
Mees ST; Mardin WA; Sielker S; Willscher E; Senninger N; Schleicher C; Colombo-Benkmann M; Haier J
Ann Surg Oncol; 2009 Aug; 16(8):2339-50. PubMed ID: 19475450
[TBL] [Abstract][Full Text] [Related]
37. Macrophage-derived exosomal microRNA-501-3p promotes progression of pancreatic ductal adenocarcinoma through the TGFBR3-mediated TGF-β signaling pathway.
Yin Z; Ma T; Huang B; Lin L; Zhou Y; Yan J; Zou Y; Chen S
J Exp Clin Cancer Res; 2019 Jul; 38(1):310. PubMed ID: 31307515
[TBL] [Abstract][Full Text] [Related]
38. Molecular and Physiological Evaluation of Pancreatic Cancer-Induced Cachexia.
Shukla SK; Dasgupta A; Mulder SE; Singh PK
Methods Mol Biol; 2019; 1882():321-333. PubMed ID: 30378066
[TBL] [Abstract][Full Text] [Related]
39. Stabilized epithelial phenotype of cancer cells in primary tumors leads to increased colonization of liver metastasis in pancreatic cancer.
Carstens JL; Yang S; Correa de Sampaio P; Zheng X; Barua S; McAndrews KM; Rao A; Burks JK; Rhim AD; Kalluri R
Cell Rep; 2021 Apr; 35(2):108990. PubMed ID: 33852841
[TBL] [Abstract][Full Text] [Related]
40. Alternatively spliced tissue factor contributes to tumor spread and activation of coagulation in pancreatic ductal adenocarcinoma.
Unruh D; Turner K; Srinivasan R; Kocatürk B; Qi X; Chu Z; Aronow BJ; Plas DR; Gallo CA; Kalthoff H; Kirchhofer D; Ruf W; Ahmad SA; Lucas FV; Versteeg HH; Bogdanov VY
Int J Cancer; 2014 Jan; 134(1):9-20. PubMed ID: 23754313
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]